NCT07568093 · RECRUITING
PARO-agitation-study
This study tests whether PARO, a robotic baby seal that responds to touch, voice and movement, can reduce agitation in adults after abdominal (visceral) surgery. Staff check agitation, pain, anxiety and delirium twice daily for three days. It is a device study with no phase, so it is not a drug trial and nothing is proven yet.
Eligibility criteria
Patient inclusion criteria: * ≥18 years of age * Elective visceral surgery * german-speaking * Patient is capable of giving informed consent Patient exclusion criteria: * Known dementia * Known immunodeficiency * Anacusia * Acute damage to the central nervous system * A preoperative systemic infection * Pre-existing severe immunosuppression or colonization with multidrug-resistant organisms (methicillin resistant Staphylococcus aureus (MRSA), quadruple multidrug-resistant Gram-negative pathogens (MRGN), Candida auris, vancomycin-resistant enterococci (VRE), and linezolid-resistant enterococci (LRE)) * Postoperative systemic infection * Drug dependence * Known chronic pain syndrome
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-05-05